User profiles for "author:Gibbs P"
![]() | Peter GibbsThe Walter and Eliza Hall Institute Of Medical Research Verified email at wehi.edu.au Cited by 36541 |
Towards the introduction of the 'Immunoscore'in the classification of malignant tumours
J Galon, B Mlecnik, G Bindea, HK Angell…�- The Journal of�…, 2014 - Wiley Online Library
Abstract The American Joint Committee on Cancer/Union Internationale Contre le Cancer
(AJCC/UICC) TNM staging system provides the most reliable guidelines for the routine�…
(AJCC/UICC) TNM staging system provides the most reliable guidelines for the routine�…
[HTML][HTML] Cancer classification using the Immunoscore: a worldwide task force
J Galon, F Pag�s, FM Marincola, HK Angell…�- Journal of translational�…, 2012 - Springer
Prediction of clinical outcome in cancer is usually achieved by histopathological evaluation
of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor�…
of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor�…
Introduction to radiomics
Radiomics is a rapidly evolving field of research concerned with the extraction of quantitative
metrics—the so-called radiomic features—within medical images. Radiomic features capture�…
metrics—the so-called radiomic features—within medical images. Radiomic features capture�…
Detection of circulating tumor DNA in early-and late-stage human malignancies
C Bettegowda, M Sausen, RJ Leary, I Kinde…�- Science translational�…, 2014 - science.org
The development of noninvasive methods to detect and monitor tumors continues to be a
major challenge in oncology. We used digital polymerase chain reaction–based�…
major challenge in oncology. We used digital polymerase chain reaction–based�…
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Earlier detection is key to reducing cancer deaths. Here, we describe a blood test that can
detect eight common cancer types through assessment of the levels of circulating proteins�…
detect eight common cancer types through assessment of the levels of circulating proteins�…
[HTML][HTML] Pembrolizumab in microsatellite-instability–high advanced colorectal cancer
T Andr�, KK Shiu, TW Kim, BV Jensen…�- …�England Journal of�…, 2020 - Mass Medical Soc
Abstract Background Programmed death 1 (PD-1) blockade has clinical benefit in
microsatellite-instability–high (MSI-H) or mismatch-repair–deficient (dMMR) tumors after�…
microsatellite-instability–high (MSI-H) or mismatch-repair–deficient (dMMR) tumors after�…
Metastasis-associated gene expression changes predict poor outcomes in patients with Dukes stage B and C colorectal cancer
RN Jorissen, P Gibbs, M Christie, S Prakash…�- Clinical Cancer�…, 2009 - AACR
Purpose: Colorectal cancer prognosis is currently predicted from pathologic staging,
providing limited discrimination for Dukes stage B and C disease. Additional markers for�…
providing limited discrimination for Dukes stage B and C disease. Additional markers for�…
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a�…
LA Diaz, KK Shiu, TW Kim, BV Jensen…�- The Lancet�…, 2022 - thelancet.com
Background Pembrolizumab has shown improved progression-free survival versus
chemotherapy in patients with newly diagnosed microsatellite instability-high or mismatch�…
chemotherapy in patients with newly diagnosed microsatellite instability-high or mismatch�…
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer
Background The role of adjuvant chemotherapy in stage II colon cancer continues to be
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor�…
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor�…
SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective�…
GA Van Hazel, V Heinemann, NK Sharma…�- Journal of Clinical�…, 2016 - ascopubs.org
Purpose SIRFLOX was a randomized, multicenter trial designed to assess the efficacy and
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin�…
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin�…